Treatment | 1-MCP | Ethephon | Fluorescence yield | Membrane damage | ||
2011 | 2012 | 2011 | 2012 | |||
g a.i. ha−1 | mL∙ha−1 | 100% | ||||
1 | 0 | 0 | 0.539cd | 0.670ab | 9.95abc | 9.92d |
2 | 0 | 146 | 0.537cd | 0.665ab | 10.30abc | 11.95ab |
3 | 0 | 292 | 0.532d | 0.662ab | 11.53ab | 11.96ab |
4 | 0 | 438 | 0.534cd | 0.660b | 11.96a | 12.06a |
5 | 10 | 0 | 0.562a | 0.677a | 8.79c | 10.88c |
6 | 10 | 146 | 0.550b | 0.676a | 9.70bc | 10.43cd |
7 | 10 | 292 | 0.543bc | 0.666ab | 9.62bc | 11.14bc |
8 | 10 | 438 | 0.536cd | 0.675ab | 10.97ab | 11.02c |
LSD (0.05) | 0.011 | 0.016 | 2.06 | 0.92 | ||
Orthogonal contrast | ||||||
Ethephon vs. ethephon + 1-MCP | ** | * | NS | ** | ||
1-MCP vs. 1-MCP absent | ** | * | * | * | ||
Control vs. ethephon | NS | NS | NS | ** | ||
1-MCP vs. 1-MCP + ethphon | ** | NS | NS | NS | ||
Ethephon vs. ethephon absent | ** | NS | * | ** |